Improving clinical research

British Medical Journal

Volumn 327, Issue 7422, 2003, Pages 999-1000

  Stewart, Paul M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; TAMOXIFEN;

BREAST CANCER; BUDGET; CAREER; CLINICAL RESEARCH; CLINICAL TRIAL; COST BENEFIT ANALYSIS; EDITORIAL; FINANCIAL MANAGEMENT; GENOME ANALYSIS; GOVERNMENT; HUMAN; INVESTMENT; LEGAL ASPECT; MEDICAL ETHICS; MEDICAL RESEARCH; OUTCOMES RESEARCH; PATIENT CARE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBLICATION; RESOURCE ALLOCATION; SURVIVAL RATE; UNITED KINGDOM;

EID: 0242288802     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7422.999     Document Type: Editorial

References (8)

1. Academy of Medical Sciences. Resuscitating clinical research in the United Kingdom. BMJ 2003;327:1041-3.
2. Academy of Medical Sciences. The tenure track clinician scientist: a new career pathway to promote recruitment into clinical practice. Report of the academy working group on academic careers. (March 2000) www.acmedsci.ac.uk/ f_pubs.htm (accessed 27 Oct 2003).
3. Medical Research Council. Last session's awards. London: MRC, 2003. www.mrc.ac.uk/index/current-research/current-last_sessions_awards (accessed 28 Oct 2003).
4. Research and Development Task Force. Supporting research and development in the NHS: a report to the minister for health by a research and development task force chaired by Professor Anthony Culyer. London: HMSO, 1994.
5. Kerr DJ. NTRAC pioneering a virtual model. Lancet Oncol 2003;4:393.
6. Pattison J. NHS Support for research. Lancet 2003;362:576.
7. Smith IE, Dowsett M. Aromatase inhibitors in breast cancer. N Engl J Med 2003;348:2431-42.
8. Miller WR, Hawkins RA, Forrest AP. Significance of aromatase activity in human breast cancer. Cancer Res 1982;42:3365-8.